M14 General Principles on Planning, Designing, Analyzing, and Reporting of Non-interventional Studies That Utilize Real-World Data for Safety Assessment of Medicines
Similar Posts
Drug Development Tool (DDT) Qualification Programs
Information about the mission and objectives of FDA’s Drug Development Tool (DDT) qualification programs.Natural Disaster Preparedness and Response | Drugs
Stay informed on FDA’s guidance for drugs used in natural disaster preparedness and response. Learn about emergency drug supplies, FDA-approved treatments, and safety measures for public health during disasters like hurricanes, floods, and more.Baxter Oncology GmbH – 09/26/2025
Baxter Oncology GmbH – 09/26/2025. Country: Germany. Record Type: 483Early Alert: TactiFlex Ablation Catheter Issue from Abbott
Abbott has issued new instructions on removing TactiFlex Ablation Catheter, Sensor Enabled from its packaging due to tip detachment issuesSteven H. Reynolds, DO. Long Beach, CA. EIR issued 11/23/2020
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/23/2020
Short Title (70 char) Steven H. Reynolds, DO. Long Beach, CA. EIR issued 11/23/2020
FEI Number 3017483836
Firm Name Steven H. Reynolds, DO
Record Type EIR
State CA
Establishment Type Clinical InvestigZapMax may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use ZapMax, a product promoted and sold for sexual enhancement on various websites, including www.amazon.com, and possibly in some retail stores.
